Methionine oxidation and aging.

It is well established that many amino acid residues of proteins are susceptible to oxidation by various forms of reactive oxygen species (ROS), and that oxidatively modified proteins accumulate during aging, oxidative stress, and in a number of age-related diseases. Methionine residues and cysteine residues of proteins are particularly sensitive to oxidation by ROS. However, unlike oxidation of other amino acid residues, the oxidation of these sulfur amino acids is reversible. Oxidation of methionine residues leads to the formation of both R- and S-stereoisomers of methionine sulfoxide (MetO) and most cells contain stereospecific methionine sulfoxide reductases (Msr's) that catalyze the thioredoxin-dependent reduction of MetO residues back to methionine residues. We summarize here results of studies, by many workers, showing that the MetO content of proteins increases with age in a number of different aging models, including replicative senescence and erythrocyte aging, but not in mouse tissues during aging. The change in levels of MetO may reflect alterations in any one or more of many different mechanisms, including (i) an increase in the rate of ROS generation; (ii) a decrease in the antioxidant capacity; (iii) a decrease in proteolytic activities that preferentially degrade oxidized proteins; or (iv) a decrease in the ability to convert MetO residues back to Met residues, due either to a direct loss of Msr enzyme levels or indirectly to a loss in the availability of the reducing equivalents (thioredoxin, thioredoxin reductase, NADPH generation) involved. The importance of Msr activity is highlighted by the fact that aging is associated with a loss of Msr activities in a number of animal tissues, and mutations in mice leading to a decrease in the Msr levels lead to a decrease in the maximum life span, whereas overexpression of Msr leads to a dramatic increase in the maximum life span.

[1]  N. Brot,et al.  Oxidation of methionine residues in proteins of activated human neutrophils. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Schöneich,et al.  Diastereoselective reduction of protein‐bound methionine sulfoxide by methionine sulfoxide reductase , 1999, FEBS letters.

[3]  C. Epstein,et al.  Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. , 2003, Physiological genomics.

[4]  W. Markesbery,et al.  Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain , 1999, Journal of neurochemistry.

[5]  C. Schöneich,et al.  Mechanism of Sulfoxide Formation through Reaction of Sulfur Radical Cation Complexes with Superoxide or Hydroxide Ion in Oxygenated Aqueous Solution , 1996 .

[6]  N. Brot,et al.  Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Epstein,et al.  Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase , 1995, Nature Genetics.

[8]  E. Stadtman Protein modification in aging. , 1988, Journal of gerontology.

[9]  N. Brot,et al.  Biochemistry and physiological role of methionine sulfoxide residues in proteins. , 1983, Archives of biochemistry and biophysics.

[10]  F. Barras,et al.  Repair of Oxidized Proteins , 2001, The Journal of Biological Chemistry.

[11]  A. Blasina,et al.  Oxidative lesion to membrane proteins in senescent erythrocytes. , 1990, Biomedica biochimica acta.

[12]  U. Costabel,et al.  Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. , 1991, The American review of respiratory disease.

[13]  K. Harada,et al.  Simultaneous racemization and isomerization at specific aspartic acid residues in alpha B-crystallin from the aged human lens. , 1994, Biochimica et biophysica acta.

[14]  E. Stadtman,et al.  Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Stadtman,et al.  Methionine residues as endogenous antioxidants in proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Lyons,et al.  Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. , 1997, The Journal of clinical investigation.

[17]  Brian W. Matthews,et al.  The mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB , 2002, Nature Structural Biology.

[18]  E. Stadtman,et al.  Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism , 2002, Molecular and Cellular Biochemistry.

[19]  S. Dhandayuthapani,et al.  Methionine Sulfoxide Reductase A (MsrA) Deficiency Affects the Survival of Mycobacterium smegmatis within Macrophages , 2004, Journal of bacteriology.

[20]  W. Pryor,et al.  Inactivation of human α-1-proteinase inhibitor by gas-phase cigarette smoke , 1984 .

[21]  C. Schöneich,et al.  Diastereoselective protein methionine oxidation by reactive oxygen species and diastereoselective repair by methionine sulfoxide reductase. , 2000, Free radical biology & medicine.

[22]  J. Wollensak,et al.  Pyrolysis mass spectra, sulfhydryl and tryptophan content of the embryonic nuclei from adult human normal and nuclear-cataractous lenses. , 1980, Biochimica et biophysica acta.

[23]  T. Squier,et al.  Progressive decline in the ability of calmodulin isolated from aged brain to activate the plasma membrane Ca-ATPase. , 1998, Biochemistry.

[24]  V. Uversky,et al.  Role of individual methionines in the fibrillation of methionine-oxidized α-synuclein , 2004 .

[25]  A. Spector,et al.  Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Michaelis,et al.  Decreased plasma membrane calcium transport activity in aging brain. , 1996, Life sciences.

[27]  N. Brot,et al.  Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Stadtman,et al.  Purification and characterization of methionine sulfoxide reductases from mouse and Staphylococcus aureus and their substrate stereospecificity. , 2002, Biochemical and biophysical research communications.

[29]  A. Brovelli,et al.  Evidence for membrane protein oxidation during in vivo aging of human erythrocytes , 1991, Mechanisms of Ageing and Development.

[30]  E. Stadtman,et al.  Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. CrastesdePaulet Free radicals and aging , 1990 .

[32]  J. Moss,et al.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. , 2000, The Journal of biological chemistry.

[33]  N. Brot,et al.  Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage , 1995, Journal of bacteriology.

[34]  N. Copeland,et al.  Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Vogt Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.

[36]  B. Friguet,et al.  Rat peptide methionine sulphoxide reductase: cloning of the cDNA, and down-regulation of gene expression and enzyme activity during aging. , 2001, The Biochemical journal.

[37]  B. Friguet,et al.  The peptide methionine sulfoxide reductases, MsrA and MsrB (hCBS‐1), are downregulated during replicative senescence of human WI‐38 fibroblasts , 2004, FEBS letters.

[38]  Theodore W Randolph,et al.  Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. , 2003, Biochemistry.

[39]  N. Brot,et al.  High-quality life extension by the enzyme peptide methionine sulfoxide reductase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Starke-Reed,et al.  Protein oxidation and proteolysis during aging and oxidative stress. , 1989, Archives of biochemistry and biophysics.

[41]  J. Rohen,et al.  Age-related changes in the composition of proteins in the trabecular meshwork of the human eye , 1983, Mechanisms of Ageing and Development.

[42]  K. Kuczera,et al.  One-Electron Photooxidation of N-Methionyl Peptides. Mechanism of Sulfoxide and Azasulfonium Diastereomer Formation through Reaction of Sulfide Radical Cation Complexes with Oxygen or Superoxide , 1998 .

[43]  C. Epstein,et al.  Increased Oxidative Damage Is Correlated to Altered Mitochondrial Function in Heterozygous Manganese Superoxide Dismutase Knockout Mice* , 1998, The Journal of Biological Chemistry.

[44]  E. Stadtman,et al.  Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Schöneich,et al.  Oxidation of methionine peptides by Fenton systems: the importance of peptide sequence, neighbouring groups and EDTA , 1996 .

[46]  E. Stadtman,et al.  The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Floyd,et al.  Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. , 1991, Proceedings of the National Academy of Sciences of the United States of America.